Iranian Journal of Pediatrics

Published by: Kowsar

Deflazacort Versus Prednisolone: Randomized Controlled Trial in Treatment of Children With Idiopathic Nephrotic Syndrome

Ravish Singhal 1 , * , Sadbhavna Pandit 1 and Neeraj Dhawan 1
Authors Information
1 Department of Pediatrics, Government Multispecialty Hospital, Chandigarh, India
Article information
  • Iranian Journal of Pediatrics: April 28, 2015, 25 (2)
  • Published Online: April 18, 2015
  • Article Type: Research Article
  • Received: February 8, 2015
  • Revised: February 15, 2015
  • Accepted: March 10, 2015
  • DOI: 10.5812/ijp.510

To Cite: Singhal R, Pandit S, Dhawan N. Deflazacort Versus Prednisolone: Randomized Controlled Trial in Treatment of Children With Idiopathic Nephrotic Syndrome, Iran J Pediatr. 2015 ;25(2):-. doi: 10.5812/ijp.510.

Abstract
Copyright © 2015, Growth & Development Research Center.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Indian Pediatric Nephrology Group IAOP. Consensus statement on management of steroid sensitive nephrotic syndrome. Indian Pediatr. 2001; 38(9): 975-86[PubMed]
  • 2. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003; 362(9384): 629-39[DOI][PubMed]
  • 3. Bagga A, Srivastava RN. Pediatric Nephrology. 2005; : 159-200
  • 4. Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int. 2001; 59(6): 2126-33[DOI][PubMed]
  • 5. Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res. 2005; 122(1): 13-28[PubMed]
  • 6. Pais P. Nelson Textbook of Pediatrics. 2011; : 1801-4
  • 7. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int. 1981; 20(6): 765-71[PubMed]
  • 8. Hagg R, Portman RJ, Milliner D. Evaluation and management of proteinuria and nephrotic syndrome in children. Recommendations from a Pediatric Nephrology Panel established at the National Kidney Foundation Conference on proteinuria, albuminuria risk, assessment, detection and elimination (PARADE). Pediatrics. 2000; 106: 1242–9
  • 9. Bagga A, Hari P, Srivastava RN. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome. Pediatr Nephrol. 1999; 13(9): 824-7[DOI][PubMed]
  • 10. Indian Pediatric Nephrology Group IAOP, Bagga A, Ali U, Banerjee S, Kanitkar M, Phadke KD, et al. Management of steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr. 2008; 45(3): 203-14[PubMed]
  • 11. Nayak S, Acharjya B. Deflazacort versus other glucocorticoids: a comparison. Indian J Dermatol. 2008; 53(4): 167-70[DOI][PubMed]
  • 12. Broyer M, Terzi F, Lehnert A, Gagnadoux MF, Guest G, Niaudet P. A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome. Pediatr Nephrol. 1997; 11(4): 418-22[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments